Generation of adenovirus by transfection of plasmids
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Biologically active fragments of Adenovirus 5 (Ad5) DNA that span the entire genome have been cloned into plasmids. The covalently attached terminal protein was removed and Eco RI linkers added in a fashion that preserves the Ad5 terminal sequences. When plasmids containing overlapping fragments that represent the entire genome are cotransfected onto 293 cells, infectious virus is obtained. Generation of virus depends upon the release of the 0 or 100 mu Ad5 terminus from pBR322 DNA by Eco RI cleavage. During virus production the modified termini of the transfected fragments are corrected exactly to that of wt viral DNA. The above method for preparing adenovirus recombinants has been used to construct a mutant, Ad5 delta (78.9-84.3), lacking most of the non-essential EIII transcriptional unit. This mutant is phenotypically wild type with respect to burst size and kinetics of growth. Surprisingly, it inhibits wt viral growth upon mixed infections of HeLa or 293 cells, apparently at the level of DNA replication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Characteristics of a human cell line transformed by DNA from human adenovirus type 5
Graham, F. L., Russell, W. C., Smiley, J., & Nairn, R. (1977) · Journal of General Virology · doi:10.1099/0022-1317-36-1-59 · Cited by 4,793
Cited by
A simplified system for generating recombinant adenoviruses
He, T.-C., Zhou, S., da Costa, L. T., Yu, J., Kinzler, K. W., & Vogelstein, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2509 · Cited by 3,206
Manipulation of Adenovirus Vectors
Graham, F. L., & Prevec, L. (2003) · Gene Transfer and Expression Protocols · doi:10.1385/0-89603-178-0:109 · Cited by 752
Bett, A. J., Haddara, W., Prevec, L., & Graham, F. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8802 · Cited by 744
Lee, C. S., Bishop, E. S., Zhang, R., Yu, X., Farina, E. M., Yan, S., Zhao, C., Zeng, Z., Shu, Y., Wu, X., et al. (2017) · Genes & Diseases · doi:10.1016/j.gendis.2017.04.001 · Cited by 691
“An early alternative to this method involved an in vitro direct ligation of the transgene-containing fragment to the linear E1/E3-deleted adenoviral genome DNA through a restriction enzyme site, such as ClaI site.(126) However, due to the large size of Ad genome, unique and useful restriction sites are limited, making…”
MethodChartier, C., Degryse, E., Gantzer, M., Dieterle, A., Pavirani, A., & Mehtali, M. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4805-4810.1996 · Cited by 653
Methods for construction of adenovirus vectors
Graham, F. L., & Prevec, L. (1995) · Molecular Biotechnology · doi:10.1007/bf02789331 · Cited by 479
Packaging capacity and stability of human adenovirus type 5 vectors
Bett, A. J., Prevec, L., & Graham, F. L. (1993) · Journal of Virology · doi:10.1128/jvi.67.10.5911-5921.1993 · Cited by 472
Siebenlist, U., Hennighausen, L., Battey, J., & Leder, P. (1984) · Cell · doi:10.1016/0092-8674(84)90368-4 · Cited by 423
Halbert, D. N., Cutt, J. R., & Shenk, T. (1985) · Journal of Virology · doi:10.1128/jvi.56.1.250-257.1985 · Cited by 381
Efficient Construction of a Recombinant Adenovirus Vector by an Improved In Vitro Ligation Method
Mizuguchi, H., & Kay1, M. A. (1998) · Human Gene Therapy · doi:10.1089/10430349850019418 · Cited by 351
Gene Therapy: Promises and Problems
Pfeifer, A., & Verma, I. M. (2001) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.2.1.177 · Cited by 340
Molecular evolution of human adenoviruses
Robinson, C. M., Singh, G., Lee, J. Y., Dehghan, S., Rajaiya, J., Liu, E. B., Yousuf, M. A., Betensky, R. A., Jones, M. S., Dyer, D. W., et al. (2013) · Scientific Reports · doi:10.1038/srep01812 · Cited by 282
Replication-Defective Vector Based on a Chimpanzee Adenovirus
Farina, S. F., Gao, G.-P., Xiang, Z. Q., Rux, J. J., Burnett, R. M., Alvira, M. R., Marsh, J., Ertl, H. C. J., & Wilson, J. M. (2001) · Journal of Virology · doi:10.1128/jvi.75.23.11603-11613.2001 · Cited by 272
Gene Therapy with Viral Vectors
Kootstra, N. A., & Verma, I. M. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140257 · Cited by 267
Redundant control of adenovirus late gene expression by early region 4
Bridge, E., & Ketner, G. (1989) · Journal of Virology · doi:10.1128/jvi.63.2.631-638.1989 · Cited by 259
Adenovirus-Based Expression Vectors and Recombinant Vaccines
Graham, F. L., & Prevec, L. (1992) · Vaccines · doi:10.1016/b978-0-7506-9265-6.50022-1 · Cited by 248
Metadata
- Authors
- Berkner, K. L., & Sharp, P. A.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1983
- Volume
- 11
- Issue
- 17
- Pages
- 6003-6020
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W2033798265
- Cited by
- 144
- References
- 1
- FWCI
- 6.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.